Status:
COMPLETED
BAR As a Mortality Predictor in Septic AKI
Lead Sponsor:
Ain Shams University
Conditions:
Acute Kidney Injury
Sepsis
Eligibility:
All Genders
18-60 years
Brief Summary
The aim of this study is to investigate the prognostic value of Blood Urea Nitrogen to serum Albumin ratio in septic Acute Kidney Injury patients Follow-up will be conducted for all enrolled patients ...
Detailed Description
A complete medical history will be obtained from all patients including age, sex, comorbidities, cause of sepsis, and SOFA and APACHE II scores at admission. Blood samples will be collected within 24...
Eligibility Criteria
Inclusion
- 18 - 60 years of age
- Fulfilled the diagnostic criteria of Sepsis 3.0 (defined as a suspected or confirmed infection with a sequential organ failure assessment (SOFA) score of 2 or higher)
- Developed AKI during hospitalization according to Kidney Disease: Improving Global Outcomes (KDIGO) guideline
Exclusion
- ICU length of stay\<24 h
- AKI occurred before current hospital admission.
- AKI is supposed to be secondary to causes other than sepsis.
- Receiving renal replacement therapy at the time of admission.
- Diagnosis with chronic kidney disease.
- Diagnosis with liver failure.
- Pregnant or lactating.
- There was insufficient data for analysis.
- Patients who had received Human serum Albumin infusion 3 days before ICU admission.
Key Trial Info
Start Date :
September 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06584149
Start Date
September 25 2023
End Date
September 25 2024
Last Update
February 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Abbassia, Egypt, 11566